Insider filing · BHC

John Paulson bought $14.7M of Bausch Health Companies (BHC)

Executed Jun 10 2025, disclosed Jun 12 2025, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Jun 12 2025), the stock returned +21.0% (delay-adjusted); from the execution session (Jun 10 2025), +35.7%. Derived: entry at the session's open, exit at the close 20 sessions later.

JP John Paulson Director profile →

John Paulson (Director) filed 4 Form 4 reports in the past 24 months (4 purchases, 0 sales), most often in Bausch Health Companies Inc. (BHC). Across 4 priced purchase filings, the average 21-session return was +17.6% from execution and +8.1% from disclosure (delay-adjusted; derived). The largest single filing was $312.5M of BHC (34,721,118 sh × $9.00, as filed), executed Aug 14 2025.

BHC Bausch Health Companies Inc. BHC · Healthcare · 8 filings in 24 months ticker →

Healthcare · Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→